Literature DB >> 29907587

Precision Prevention and Early Detection of Cancer: Fundamental Principles.

Timothy R Rebbeck1,2, Karen Burns-White3, Andrew T Chan4,5,6, Karen Emmons2, Matthew Freedman3,5, David J Hunter2, Peter Kraft2, Francine Laden2,6, Lorelei Mucci2, Giovanni Parmigiani3,2, Deborah Schrag3,5, Sapna Syngal3,5, Rulla M Tamimi2,6, Kasisomayajula Viswanath3,2, Matthew B Yurgelun3,5, Judy E Garber3,5.   

Abstract

Prevention and early detection is critical for reducing the population cancer burden. Two approaches have been used: Population approaches change social norms (e.g., smoking bans) or impose incentives (e.g., cigarette taxes); high-risk strategies intervene upon individuals with elevated cancer risk (e.g., smoking cessation). Knowledge about carcinogenesis mechanisms, extreme exposures, and inherited susceptibility provides opportunities to develop precision prevention and early-detection (PPED) strategies. PPED aims to understand the basis of risk, identify groups that optimally benefit from interventions, characterize heterogeneity in intervention responses, optimize intervention timing, and minimize toxicities. We propose a framework around which PPED strategies can be developed. Currently available cancer prevention and early-detection approaches have the potential to reduce a large proportion of the cancer burden in the population. However, even if fully implemented, existing methods cannot fully eliminate the cancer burden. New PPED approaches that exploit the growing knowledge of molecular and biological cancer mechanisms should be developed and implemented. Cancer Discov; 8(7); 803-11. ©2018 AACR. ©2018 American Association for Cancer Research.

Entities:  

Year:  2018        PMID: 29907587     DOI: 10.1158/2159-8290.CD-17-1415

Source DB:  PubMed          Journal:  Cancer Discov        ISSN: 2159-8274            Impact factor:   39.397


  18 in total

1.  NSAIDs and Colorectal Cancer Phenotypes: What Now?

Authors:  Elizabeth L Barry; Veronika Fedirko; John A Baron
Journal:  J Natl Cancer Inst       Date:  2019-05-01       Impact factor: 13.506

2.  Older breast cancer survivors may harbor hereditary cancer predisposition pathogenic variants and are at risk for clonal hematopoiesis.

Authors:  Thomas P Slavin; Can-Lan Sun; Yanin Chavarri-Guerra; Mina S Sedrak; Vani Katheria; Danielle Castillo; Josef Herzog; William Dale; Arti Hurria; Jeffrey N Weitzel
Journal:  J Geriatr Oncol       Date:  2019-09-28       Impact factor: 3.599

3.  Interest in genetic testing and risk-reducing behavioral changes: results from a community health assessment in New York City.

Authors:  Sarah M Lima; Meaghan Nazareth; Karen M Schmitt; Andria Reyes; Elaine Fleck; Gary K Schwartz; Mary Beth Terry; Grace C Hillyer
Journal:  J Community Genet       Date:  2022-10-13

4.  Developing an algorithm across integrated healthcare systems to identify a history of cancer using electronic medical records.

Authors:  Jennifer C Gander; Mahesh Maiyani; Larissa L White; Andrew T Sterrett; Brianna Güney; Pamala A Pawloski; Teri DeFor; YuanYuan Olsen; Benjamin A Rybicki; Christine Neslund-Dudas; Darsheen Sheth; Richard Krajenta; Devaki Purushothaman; Stacey Honda; Cyndee Yonehara; Katrina A B Goddard; Yolanda K Prado; Habibul Ahsan; Muhammad G Kibriya; Briseis Aschebrook-Kilfoy; Chun-Hung Chan; Sarah Hague; Christina L Clarke; Brooke Thompson; Jennifer Sawyer; Mia M Gaudet; Heather Spencer Feigelson
Journal:  J Am Med Inform Assoc       Date:  2022-06-14       Impact factor: 7.942

Review 5.  Single-cell profiling of tumour evolution in multiple myeloma - opportunities for precision medicine.

Authors:  Ankit K Dutta; Jean-Baptiste Alberge; Romanos Sklavenitis-Pistofidis; Elizabeth D Lightbody; Gad Getz; Irene M Ghobrial
Journal:  Nat Rev Clin Oncol       Date:  2022-01-11       Impact factor: 65.011

6.  NKX3.1 Localization to Mitochondria Suppresses Prostate Cancer Initiation.

Authors:  Alexandros Papachristodoulou; Aditya Dutta; Antonio Rodriguez-Calero; Sukanya Panja; Elizabeth Margolskee; Renu K Virk; Teresa A Milner; Luis Pina Martina; Jaime Y Kim; Matteo Di Bernardo; Alanna B Williams; Elvis A Maliza; Joseph M Caputo; Christopher Haas; Vinson Wang; Guarionex Joel De Castro; Sven Wenske; Hanina Hibshoosh; James M McKiernan; Michael M Shen; Mark A Rubin; Antonina Mitrofanova; Cory Abate-Shen
Journal:  Cancer Discov       Date:  2021-04-23       Impact factor: 39.397

7.  Metabolomics as a Tool for Biomarker Discovery in Gastric Cancer.

Authors:  David A Drew; Samuel J Klempner; Andrew T Chan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2021-09       Impact factor: 4.254

Review 8.  Artificial intelligence in oncology: Path to implementation.

Authors:  Isaac S Chua; Michal Gaziel-Yablowitz; Zfania T Korach; Kenneth L Kehl; Nathan A Levitan; Yull E Arriaga; Gretchen P Jackson; David W Bates; Michael Hassett
Journal:  Cancer Med       Date:  2021-05-07       Impact factor: 4.452

Review 9.  Integrated imaging and molecular analysis to decipher tumor microenvironment in the era of immunotherapy.

Authors:  Jia Wu; Aaron T Mayer; Ruijiang Li
Journal:  Semin Cancer Biol       Date:  2020-12-05       Impact factor: 17.012

10.  Blood cancer health disparities in the United States Hispanic population.

Authors:  Alfonso E Bencomo-Alvarez; Andres J Rubio; Mayra A Gonzalez; Anna M Eiring
Journal:  Cold Spring Harb Mol Case Stud       Date:  2021-04-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.